Abstract
Successful treatment of eye diseases requires effective concentration of drug at the eye for sufficient period of time. Conventional ocular drug delivery including eye drops, systemic administration, ophthalmic ointments, is no longer sufficient to combat ocular diseases. This article reviews the constraints with conventional ocular therapy, and explores various novel approaches, to improve the ocular bioavailability of drugs to the anterior chamber of the eye.
Keywords: Ocular drug delivery, anterior chamber of eye, new drug delivery systems
Related Journals
Current Drug Research Reviews
Cardiovascular & Hematological Disorders-Drug Targets
Applied Drug Research, Clinical Trials and Regulatory Affairs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Anti-Infective Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Related Books
Bioactive Phytochemicals: Drug Discovery to Product Development
Biologically Active Natural Products from Asia and Africa: A Selection of Topics
Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Postbiotics: Science, Technology and Applications
Solubility, Delivery and ADME Problems of Drugs and Drug-Candidates
The Pharmaceutical Scientist Guide to Solution Kinetic Models Mathematical Description and Applications
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Pharmaceutical Chemistry and Production: An Introductory Textbook
25